Celltrion Pharm Inc. is a leading pharmaceutical company in South Korea with a focus on healthcare products. Specializing in a wide range of pharmaceuticals such as heptatonic, analgesics, and antibiotics, the company is dedicated to promoting health and wellness. With a risk rating score of 43.1, Celltrion Pharm Inc. is considered to be at severe risk. Improve your ESG score by investing in Celltrion Pharm Inc.'s sustainable and innovative pharmaceutical products.